GoldBamboo.com - Knowledge is strong medicine
  

Irinotecan - Blogs


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:





Irinotecan

Camptosar 



Recent Blog Posts



View Post: World Journal of Surgical Oncology
Full text
Transarterial ... ...
View Blog: Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report. Robert CG Martin1 email , Ken Robbins2 email



View Post: Phase I/II study of sequential therapy with irinotecan and S-1 for ...
19 Nov 2009 by C Ishioka  
Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer. British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605432. Authors: T Yoshioka, S Kato, M Gamoh, ...
View Blog: British Journal of Cancer - AOP - nature.com... - http://feeds.nature.com/bjc/rss/aop



View Post: Gefitinib Increases Serum Concentrations of Oral Irinotecan and SN ...
2 Oct 2008
We evaluated the effects of oral gefitinib on pharmacokinetic parameters of orally coadministered irinotecan. Methods: We measured the serum pharmacokinetic parameters and biliary excretion of irinotecan, SN-38 and its glucuronide after ...
View Blog: American Journal of Nephrology : Last 20 articles - http://content.karger.com/



View Post: RCT: Irinotecan plus cisplatin vs. S-1 vs. fluorouracil for ...
9 Oct 2009
Following reports of promising findings with irinotecan plus cisplatin and S-1 (tegafur, 5-chloro-2,4-dihydropyrimidine, and potassium oxonate), Japanese researchers conducted a phase III open label randomised trial to investigate the ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/



View Post: Association of Molecular Markers With Toxicity Outcomes in a ...
18 Nov 2009 by Braun, Richman, Thompson, Daly, Meade,...  
Patients allocated first-line FU had planned second-line irinotecan alone, IrFU, or OxFU. The primary toxicity outcome measure was toxicity-induced delay or dose reduction; the secondary outcome was Common Terminology Criteria of ...
View Blog: Journal of Clinical Oncology Current Issue - http://jco.ascopubs.org/



View Post: UGT1A1 gene polymorphism: Impact on toxicity and efficacy of ...
5 Nov 2009 by Schulz C, Heinemann V, Schalhorn A, Moosmann...  
AIM: To investigate the correlation between uridine diphosphate glucuronosyl transferase 1A1 (UGT1A1) gene polymorphisms and irinotecan-associated side effects and parameters of drug efficacy in patients with metastatic colorectal ...
View Blog: JournalFeeds - http://journalfeeds.com/



Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource for Irinotecan.

December 4, 2009



Page Updated: June 1, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.